Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 87
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.01-083 - Phase 2 Study of MEDI4736 in Patients with PD-L1+ Locally Advanced or Metastatic Stage IIIb-IV NSCLC Treated with ≥ 2 Prior Regimens (ATLANTIC)

      09:30 - 09:30  |  Author(s): M.C. Garassino

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 02 - PD1 Axis Immunotherapy 2

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:E.B. Garon
    • Coordinates: 9/07/2015, 10:45 - 12:15, Four Seasons Ballroom F1+F2
    • +

      ORAL02.01 - Phase 3, Randomized Trial (CheckMate 017) of Nivolumab (NIVO) vs Docetaxel in Advanced Squamous (SQ) Cell Non-Small Cell Lung Cancer (NSCLC)

      10:45 - 10:56  |  Author(s): K. Reckamp

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL02.03 - Longer-Term Follow-Up of a Phase 2 Study (CheckMate 063) of Nivolumab in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer

      11:07 - 11:18  |  Author(s): L. Horn

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL02.05 - Safety and Efficacy of First-Line Nivolumab (NIVO; Anti-Programmed Death-1 [PD-1]) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC)

      11:28 - 11:39  |  Author(s): N.A. Rizvi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS 04 - Harnessing the Full Potential of the Immune System

    • Type: Mini Symposium
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 5
    • Moderators:C. Butts
    • Coordinates: 9/07/2015, 14:15 - 15:45, Four Seasons Ballroom F3+F4
  • +

    MINI 03 - PD1 Axis Inhibition and EGFR

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 11
    • Moderators:L. Gandhi
    • Coordinates: 9/07/2015, 16:45 - 18:15, Four Seasons Ballroom F1+F2
  • +

    ORAL 13 - Immunotherapy Biomarkers

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 8
    • Moderators:D. Kim
    • Coordinates: 9/07/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
    • +

      ORAL13.03 - Spatiotemporal Effects on Programmed Death Ligand 1 (PD-L1) Expression and Immunophenotype of Non-Small Cell Lung Cancer (NSCLC)

      17:07 - 17:18  |  Author(s): M. Kowanetz

      • Abstract

      Loading...

  • +

    ORAL 41 - Immune Biology, Microenvironment and Novel Targets

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 8
    • Moderators:S.K. Padda
    • Coordinates: 9/09/2015, 18:30 - 20:00, Four Seasons Ballroom F1+F2
    • +

      ORAL41.04 - Discussant for ORAL41.01, ORAL41.02, ORAL41.03

      19:03 - 19:13  |  Author(s): N.A. Rizvi

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.